Oracle Runs

Will the results be positive?

Trial completed per multiple sources, but Biogen terminated Part 2 of FUSION study. Part 1 monotherapy readout expected Q2 2026 per Biogen slides and news. No topline results, efficacy data, or public readout posted on ClinicalTrials.gov or Biogen site as of April 2026. Evidence incomplete, no clear positive/negative framing.

Will the results be positive?

Trial listed as completed (primary ~Feb 2026) but no public efficacy readout or results posted on clinicaltrials.gov. Part 2 (combo) terminated as strategic decision; monotherapy data expected Q2 2026. No source frames this exact trial as positive or negative.

Will the results be positive?

ClinicalTrials.gov lists this study as completed but without posted results, so there is no clear public trial-specific basis yet to call the readout positive or negative.

Will the results be positive?

No trial-specific efficacy/safety readout was found. The study is completed, but cited sources indicate no results have been posted yet and top-line data disclosure remains the next milestone, so there is no clear public basis to call this Phase 2 trial positive or negative.

Will the results be positive?

No clear public efficacy readout was found for this exact Phase 2 trial. The registry-derived listing says no results are posted, and contemporaneous news only says Biogen halted the combo portion/Part 2, without framing this trial’s data as positive or negative. That is insufficient for a yes/no call.